1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
  1. Beenthere2Hippie
    UNITED STATES - On Tuesday, the family of deceased musician and celebrated marijuana user Bob Marley announced what it claimed will be the first global cannabis brand, Marley Natural. Marijuana is a growth industry—and increasingly, a legal one. When the smoke cleared after the November 2014 election in the United States, two new states, Alaska and Oregon, as well as the District of Columbia had legalized the recreational sale of marijuana. They joined Washington and Colorado, which legalized pot in the 2012 election, as well as two dozen states that have decriminalized possession to accomplish something that hadn’t been done in 81 years—make an illegal drug legal.

    Of course, the question remains: How will state residents be able to buy, sell, and use something that is still against federal law? But in the absence of enforcement action by the United States government, perhaps the better question is, what will the inevitable national market in marijuana shake out? Will it consist of grungy underground head shops? Designer weed boutiques? Or will “Big Marijuana” companies—perhaps the existing “big tobacco” powerhouses—muscle their way in and perpetrate “The Bud Light-ification of Bud,” as the New York Times suggested?

    Those pursuing answers need look no further than the Mile High City and its surrounding environs, where the first great experiment in selling smoke is already under way. Marijuana for recreational use officially went on sale in Denver and across Colorado in January 2014.

    In a new case study to be available shortly, Marketing Marijuana in Colorado, Harvard Business School marketing professor John A. Quelch and coauthor David Lane look at lessons from the first few months of legalization to see what they may tell us about eventual trends. Quelch, the Charles Edward Wilson Professor of Business Administration, holds a joint appointment at Harvard School of Public Health as Professor in Health Policy and Management.

    Creating Demand

    One big open question is the degree to which illegal demand will be significantly diminished by the availability of recreational marijuana, says Quelch. “And a second is, how much will overall demand increase—since, now that it’s legal, you’ll have people demanding it who wouldn’t have demanded it before.” Early indications are that demand is there—and growing.

    Despite tight regulation, between January and July the number of retail marijuana licenses grew in Colorado from 37 to 200, along with creation of 500 medical marijuana dispensaries. Most recreational buyers seemed to be casual users. In fact, for those six months, recreational marijuana accounted for 80% of the $25 million in tax revenue from marijuana sales, with the state predicting $134 million in the next fiscal year.

    As Quelch found in his research, however, the picture is more complicated than medical versus recreational users.

    “You really have four markets,” says Quelch, “medicinal, individual grower, recreational, and the illegal market.” Each segment shows different dynamics in terms of its sensitivity to price, marketing, and convenience.

    Medicinal consumers, for example, do not care so much about variety. “Once you find the strain and supply source that best alleviates your pain, you are going to stick with it,” says Quelch. But medicinal users are frequent customers so they do care about price. “They do not need to buy it at a fancy store—they’ll go to a back alley basement shop as long as the product delivers.”

    By Michael Blanding - Forbes Magazine Online/Nov. 19, 2014
    Photo: The Daily Chronicle
    Newshawk Crew

    Author Bio

    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.


To make a comment simply sign up and become a member!